EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

The Prognosis of Males and Females With Moderate or Severe Secondary Mitral Valve Regurgitation and Avenues for Improvement

Jelle P Man, Berto J Bouma, M A Molenaar, Steven A J Chamuleau, Mark J Schuuring

Echocardiography · 2025

DOI: 10.1111/echo.70370 ↗

At a glance

Journal article in Echocardiography, 2025. Written by Jelle P Man and 4 co-authors. Institution: Department of Cardiology, Amsterdam UMC, Amsterdam, the Netherlands. Major MEDLINE topics: Mitral Valve Insufficiency, Echocardiography. 16 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aims

To understand prognostic differences between sexes in (subtypes of) secondary mitral valve regurgitation (SMR) and to identify avenues for improvement. Method and results In this retrospective study, all consecutive patients diagnosed with moderate or severe SMR by echocardiographic assessment between January 1, 2014, and June 1, 2021 were included. Sex‐specific analyses were performed using Cox proportional hazards analysis, adjusted for significant covariates. A total of 1245 patients with SMR (43% female) were included. Females more often had atrial SMR (233 (29%) females vs. 200 (21%) males, p < 0.01), males more often ischemic SMR (100 females (12%) vs. 245 males (25%), p < 0.01), and there were no significant differences between sexes in the proportion of non‐ischemic SMR (199 (25%) females vs. 268 (28%) males, p = 0.99). The estimated 5‐year survival was 70% (CI = 68%, 73%). Median follow‐up was 4.3 years [2.7–6.2], 236 males and 128 females died during follow‐up. Females had a better survival than males in a multivariable Cox model (HR = 0.67, p < 0.01).

Conclusion

Overall survival in patients with SMR was low with an estimated 5‐year survival of 70%. Females had a better survival in patients with SMR than males. The lower survival in males with SMR might be due to a larger proportion of atrial SMR in females, fewer patients with ischemic SMR, and lower ejection fractions in males with non‐ischemic SMR. The current focus on rapid heart failure medication optimization may improve the prognosis of the most vulnerable group; future studies can be directed to see whether this will be the case.

Subjects

MeSH terms (MEDLINE)

Mitral Valve InsufficiencyEchocardiographyHumansFemaleMaleRetrospective StudiesPrognosisSex FactorsMiddle AgedAgedSeverity of Illness IndexMitral ValveSurvival Rate

Author keywords

genderoutcomevalvular heart disease

Authors and institutions

  • Department of Cardiology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Netherlands Heart Institute, Utrecht, the Netherlands.
  • Department of Cardiology, Medical Spectrum Twente, Enschede, the Netherlands.
  • Department of Biomedical Signals and Systems, University of Twente, Enschede, the Netherlands.

Cite

APA

Man, J. P., Bouma, B. J., Molenaar, M. A., Chamuleau, S. A. J., & Schuuring, M. J. (2025). The Prognosis of Males and Females With Moderate or Severe Secondary Mitral Valve Regurgitation and Avenues for Improvement. Echocardiography. https://doi.org/10.1111/echo.70370

Vancouver

Man JP, Bouma BJ, Molenaar MA, Chamuleau SAJ, Schuuring MJ. The Prognosis of Males and Females With Moderate or Severe Secondary Mitral Valve Regurgitation and Avenues for Improvement. Echocardiography. 2025. doi:10.1111/echo.70370

BibTeX
@article{Man2025,
  author = {Man, Jelle P and Bouma, Berto J and Molenaar, M A and Chamuleau, Steven A J and Schuuring, Mark J},
  title = {The Prognosis of Males and Females With Moderate or Severe Secondary Mitral Valve Regurgitation and Avenues for Improvement},
  journal = {Echocardiography},
  year = {2025},
  doi = {10.1111/echo.70370}
}
Start for free →